PAVmed Inc. (PAVM) financial statements (2021 and earlier)

Company profile

Business Address ONE GRAND CENTRAL PLACE
NEW YORK, NY 10165
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments176821
Cash and cash equivalents176821
Prepaid expense   00
Other undisclosed current assets20000
Total current assets:197821
Noncurrent Assets
Property, plant and equipment  000
Other noncurrent assets1    
Other undisclosed noncurrent assets 1  0
Total noncurrent assets:11000
TOTAL ASSETS:207821
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:24321
Accounts payable 2211
Accrued liabilities 1110
Employee-related liabilities2    
Other undisclosed accounts payable and accrued liabilities1    
Debt15 8  
Other undisclosed current liabilities 8 1 
Total current liabilities:17121131
Noncurrent Liabilities
Long-term debt and lease obligation   2 
Long-term debt, excluding current maturities   2 
Total noncurrent liabilities:   2 
Other undisclosed liabilities3    
Total liabilities:20121141
Stockholders' equity
Stockholders' equity attributable to parent, including:2(4)(2)(3)(0)
Common stock00000
Additional paid in capital884833147
Accumulated deficit(88)(54)(37)(18)(8)
Other undisclosed stockholders' equity attributable to parent3221 
Stockholders' equity attributable to noncontrolling interest(2)(1)(0)  
Total stockholders' equity:(0)(5)(2)(3)(0)
TOTAL LIABILITIES AND EQUITY:207821

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Operating expenses(23)(14)(11)(8)(6)
Operating loss:(23)(14)(11)(8)(6)
Nonoperating expense
(Other Nonoperating expense)
(13)(3)(8)(1) 
Interest and debt expense(6)2(1)(1) 
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes6(2)11 
Loss from continuing operations before income taxes:(36)(17)(18)(10)(6)
Income tax benefit98 1 
Loss before gain (loss) on sale of properties:(27)(9)(18)(9)(6)
Other undisclosed net income (loss)(9)(8)18  
Net income (loss):(36)(17)0(9)(6)
Net income attributable to noncontrolling interest210  
Other undisclosed net loss attributable to parent  (18)(1) 
Net loss attributable to parent:(34)(16)(18)(10)(6)
Preferred stock dividends and other adjustments  (0)(0) 
Other undisclosed net loss available to common stockholders, basic(0)(0)(1)(1) 
Net loss available to common stockholders, diluted:(35)(17)(19)(10)(6)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Net income (loss):(36)(17)0(9)(6)
Comprehensive income (loss):(36)(17)0(9)(6)
Comprehensive income, net of tax, attributable to noncontrolling interest210  
Comprehensive income (loss), net of tax, attributable to parent:(34)(16)0(9)(6)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: